Tesofensine, also known as NS2330, is technically classified as a presynaptic serotonin–noradrenaline–dopamine reuptake inhibitor. Its pharmacological action leads to the inhibition of the reabsorption of these neurotransmitters by the central nervous system, resulting in reduced feelings of hunger. This compound primarily acts as an appetite suppressant while also influencing fat oxidation and resting energy expenditure. […]Read More